Global Alopecia Market is Expected to Grow at a CAGR of 8.6% in the Forecast Period of 2024-2032.

The global alopecia market is being driven by the rising prevalence of the disease due to surging consumption of tobacco, cigarettes and alcohol, unhealthy food habits, and rising stress indices among the working-class population, which are seen as potential causes for the disease. Moreover, the expanding geriatric population, along with a high demand for surgical hair transplants, is expected to further the market growth. In addition, it is anticipated that increased incidences of chronic diseases such as rheumatoid arthritis, polycystic ovary syndrome (PCOS), acute stress disorder, hyperthyroidism, hypothyroidism, cancer, lupus, and hypopituitarism will fuel market growth as they to contribute to the occurrence of alopecia.

North America is one of the leading markets for alopecia owing to the development in technology, increasing prevalence of the disease among the population, and rising disposable incomes. The Asia Pacific region is expected to demonstrate the fastest growth in the coming years. The key factors driving the regional market growth are the large population base and rising consumer awareness of available treatment options. Improvement in the economy and increased per capita healthcare expenses are projected to introduce strong commercial opportunities in developing countries such as India, China, and Singapore for the market.

The global alopecia market is being driven by the rising R&D activities taking place in the industry and the growing approvals of new drugs by governmental organisations. In March 2021, Eli Lilly and Incyte Corporation (NASDAQ: INCY) announced that the FDA had granted baricitinib the designation of breakthrough therapy for treating patients with alopecia areata.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis by Disease Type, Drug Type, Route of Administration, Gender, Distribution Channel, and Region:

• The market on the basis of disease type can be divided into androgenic alopecia, alopecia areata, ciatricial alopecia, traction alopecia, and alopecia totalis. 

• Based on drug type, the industry can be divided into Minoxidil and Finasteride, among others.

• Based on the route of administration, the industry can be divided into oral, topical, and injectable.

• Based on gender, the industry can be divided into males and females.

• The distribution channels in the alopecia market include hospitals, retail pharmacies, and online pharmacies.

• The regional markets for alopecia include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• The global alopecia market is being driven by the increasing global prevalence of alopecia and the rise in global healthcare expenditure.

• The technological advancements in alopecia treatment is furthering the market growth.

• The growing consumer awareness about the disease and treatments and the rising emphasis on outer appearance is catalysing the growth of the market.

Key Offerings of the Report:

• The EMR report gives an overview of the global alopecia market for the periods (2018-2023) and (2024-2032).

• The report also offers the historical (2018-2023) and forecast (2024-2032) markets for disease types, drug types, routes of administration, genders, distribution channels, and major regions of the global alopecia market.

• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global alopecia market are Cipla Ltd., Capillus LLC, Freedom Laser Therapy, Inc., Apira Science, Inc., HairMax (Lexington Intl., LLC), Follica, Inc., and Incyte Corporation, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790